Literature DB >> 25428872

The level of viral infection of antigen-presenting cells correlates with the level of development of Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Young Hee Jin1, Hyun Seok Kang1, Wanqiu Hou1, Liping Meng1, Byung S Kim2.   

Abstract

UNLABELLED: Intracerebral infection with Theiler's murine encephalomyelitis virus (TMEV) induces immune-mediated demyelinating disease in susceptible SJL/J mice but not in resistant C57BL/6 mice. Previous studies have indicated that the major histocompatibility complex (MHC) genes play the most prominent role in the development of TMEV-induced demyelinating disease. In this study, we used C57BL/6.S (B6.S) congenic mice, which carry H-2(s) MHC genes instead of H-2(b) MHC genes in conjunction with the C57BL/6 (B6) background genes. Our data show that virus-infected B6.S mice are free from disease and have significantly lower viral loads than susceptible SJL mice, particularly in the spinal cord. A strong protective Th1-type T helper response with virtually no pathogenic Th17 response was detected in B6.S mice, in contrast to the reduced Th1- and robust Th17-type responses in SJL mice. Notably, lower levels of viral infectivity in B6.S antigen-presenting cells (APCs) correlated with the disease resistance and T-cell-type response. In vitro studies using APCs from B6.S and SJL mice show that TLR2, -3, -4, and -7, but not TLR9, signaling can replace viral infection and augment the effect of viral infection in the differentiation of the pathogenic Th17 cell type. Taken together, these results strongly suggest that the viral replication levels in APCs critically affect the induction of protective versus pathogenic Th cell types via the signaling of pattern recognition receptors for innate immune responses. Our current findings further imply that the levels of viral infectivity/replication and TLR-mediated signaling play critical roles in the pathogenesis of chronic viral diseases. IMPORTANCE: This study indicates that innate immune cytokines produced in antigen-presenting cells stimulating the T cell immune responses during early viral infection play a critical role in determining the susceptibility of mice to the development of demyelinating disease. The level of innate immune cytokines reflects the level of initial viral infection in the antigen-presenting cells, and the level determines the development of T cell types, which are either protective or pathogenic. The level of initial viral infection to the cells is controlled by a gene or genes that are not associated with the major histocompatibility antigen complex genes. This finding has an important implication in controlling not only chronic viral infections but also infection-induced autoimmune-like diseases, which are closely associated with the pathogenic type of T cell responses.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25428872      PMCID: PMC4300758          DOI: 10.1128/JVI.02471-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system.

Authors:  Arièle Azoulay-Cayla; Sylvie Syan; Michel Brahic; Jean-François Bureau
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

Review 2.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

3.  H-2 Dd transgene suppresses Theiler's virus-induced demyelination in susceptible strains of mice.

Authors:  M Rodriguez; C S David
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

Review 4.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 5.  The role of CD4+ T-cells in the development of MS.

Authors:  Sylvia Delgado; William A Sheremata
Journal:  Neurol Res       Date:  2006-04       Impact factor: 2.448

6.  Differential virus replication, cytokine production, and antigen-presenting function by microglia from susceptible and resistant mice infected with Theiler's virus.

Authors:  Young-Hee Jin; Mani Mohindru; Min H Kang; Alyson C Fuller; Bongsu Kang; Daniel Gallo; Byung S Kim
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

7.  Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3.

Authors:  Eui Young So; Min Hyung Kang; Byung S Kim
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

8.  Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.

Authors:  L C Pullen; S H Park; S D Miller; M C Dal Canto; B S Kim
Journal:  J Immunol       Date:  1995-11-01       Impact factor: 5.422

9.  Demyelination induced by Theiler's virus: influence of the H-2 haplotype.

Authors:  M Rodriguez; C S David
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

10.  Role of dendritic cells in differential susceptibility to viral demyelinating disease.

Authors:  Wanqiu Hou; Eui Young So; Byung S Kim
Journal:  PLoS Pathog       Date:  2007-08-24       Impact factor: 6.823

View more
  9 in total

1.  Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.

Authors:  Seung Jae Kim; Young-Hee Jin; Byung S Kim
Journal:  PLoS One       Date:  2017-04-26       Impact factor: 3.240

2.  Virus-triggered spinal cord demyelination is followed by a peripheral neuropathy resembling features of Guillain-Barré Syndrome.

Authors:  Eva Leitzen; Barbara B Raddatz; Wen Jin; Sandra Goebbels; Klaus-Armin Nave; Wolfgang Baumgärtner; Florian Hansmann
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

3.  Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.

Authors:  Tyler C Moore; Ronald J Messer; Lorena M Gonzaga; Jennifer M Mather; Aaron B Carmody; Wibke Bayer; Elisabeth Littwitz-Salomon; Ulf Dittmer; Kim J Hasenkrug
Journal:  mBio       Date:  2019-01-22       Impact factor: 7.867

4.  Infection and Activation of B Cells by Theiler's Murine Encephalomyelitis Virus (TMEV) Leads to Autoantibody Production in an Infectious Model of Multiple Sclerosis.

Authors:  Young-Hee Jin; Charles X Kim; Jocelin Huang; Byung S Kim
Journal:  Cells       Date:  2020-07-27       Impact factor: 6.600

Review 5.  Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Byung S Kim
Journal:  Int J Mol Sci       Date:  2021-05-17       Impact factor: 5.923

6.  Transgenic expression of non-structural genes of Theiler's virus suppresses initial viral replication and pathogenesis of demyelination.

Authors:  Hyun Seok Kang; Jinjong Myoung; Eui Young So; Young Yil Bahk; Byung S Kim
Journal:  J Neuroinflammation       Date:  2016-06-01       Impact factor: 8.322

7.  Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease.

Authors:  Min H Kang; Young H Jin; Byung S Kim
Journal:  Front Cell Infect Microbiol       Date:  2018-01-23       Impact factor: 5.293

8.  Rapid Expansion of Virus-Specific CD4+ T Cell Types in the CNS of Susceptible Mice Infected with Theiler's Virus.

Authors:  Hyun Seok Kang; Wanqiu Hou; Byung S Kim
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

9.  Transcriptome analysis following neurotropic virus infection reveals faulty innate immunity and delayed antigen presentation in mice susceptible to virus-induced demyelination.

Authors:  Malgorzata Ciurkiewicz; Stefan Floess; Michael Beckstette; Maren Kummerfeld; Wolfgang Baumgärtner; Jochen Huehn; Andreas Beineke
Journal:  Brain Pathol       Date:  2021-07-06       Impact factor: 6.508

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.